MARKET

ECOR

ECOR

Electrocore
NASDAQ
6.86
-0.30
-4.19%
Opening 13:38 03/27 EDT
OPEN
7.15
PREV CLOSE
7.16
HIGH
7.15
LOW
6.67
VOLUME
84.80K
TURNOVER
--
52 WEEK HIGH
19.49
52 WEEK LOW
5.32
MARKET CAP
49.34M
P/E (TTM)
-4.3188
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ECOR last week (0317-0321)?
Weekly Report · 3d ago
Weekly Report: what happened at ECOR last week (0310-0314)?
Weekly Report · 03/17 11:47
electroCore Is Maintained at Buy by Ladenburg Thalmann
Dow Jones · 03/13 20:51
electroCore Price Target Cut to $26.00/Share From $28.00 by Ladenburg Thalmann
Dow Jones · 03/13 20:51
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 03/13 12:09
electroCore Price Target Maintained With a $25.00/Share by HC Wainwright & Co.
Dow Jones · 03/13 10:56
HC Wainwright & Co. Reiterates Buy on electroCore, Maintains $25 Price Target
Benzinga · 03/13 10:46
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
NASDAQ · 03/12 21:15
More
About ECOR
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.

Webull offers electroCore, Inc. stock information, including NASDAQ: ECOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ECOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ECOR stock methods without spending real money on the virtual paper trading platform.